Alveolar Soft Tissue Sarcoma

Description

Alveolar soft part sarcoma is an unusual tumor with highly characteristic histopathology and ultrastructure, controversial histogenesis, and enigmatic clinical behavior (Lieberman et al., 1989; Ordonez, 1999). The typical histology of ASPS shows well-defined nests of cells with abundant pink cytoplasm. The loss of central cohesion produces a pseudoalveolar appearance (Ladanyi et al., 2001).

Clinical Features

Phenotypes and symptoms related to Alveolar Soft Tissue Sarcoma

  • Neoplasm
  • Pain
  • Headache
  • Cough
  • Chest pain
  • Sarcoma
  • Paraganglioma
  • Soft tissue sarcoma
  • Alveolar soft part sarcoma

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Alveolar Soft Tissue Sarcoma Is also known as alveolar soft part sarcoma, asps.

Researches and researchers

Doctors, researchs, and experts related to Alveolar Soft Tissue Sarcoma extracted from public data.

Alveolar Soft Tissue Sarcoma Experts map



Current Researchs and researchers

  • WIEN — Pr Thomas BRODOWICZ

    Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project

    • Institution/s:
      — Universitätsklinik für Innere Medizin I, Allgemeines Krankenhaus der Stadt Wien
    • Research area/topic::

      E-TRAB: Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)



Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Alveolar Soft Tissue Sarcoma Recommended genes panels

Panel Name, Specifity and genes Tested/covered
ASPSCR1.

By Fulgent Genetics Fulgent Genetics (United States).

ASPSCR1
Specificity
100 %
Genes
50 %
Hemato-oncology chromosomal microarray.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center (United States).

BLM, BRAF, BRCA1, BRCA2, SMARCB1, KDM5C, SMO, ABI1, SSX1, SSX2, SSX4, SS18, STAG2, STAT5B, TAF15, TCF12, TERT, TFE3, TFEB, TP53 , (...)

View the complete list with 69 more genes
Specificity
3 %
Genes
100 %
Caris MI TumorSeek 592-Gene NGS Panel.

By Caris Life Sciences (United States).

BCL6, BCL7A, BCL9, BCR, ROS1, RPL10, RPL22, RPL5, RPN1, RUNX1, BLM, SDC4, SDHB, SDHC, SDHD, BMPR1A, SET, SF3B1, SFPQ, SRSF2 , (...)

View the complete list with 559 more genes
Specificity
1 %
Genes
100 %
Tempus xO assay.

By Tempus Labs, Inc. (United States).

BCL6, RHEB, RIPK1, RIPK2, RIPK3, RIT1, BCL7A, BCL9, BCR, ROBO2, ROCK1, ROCK2, ROR1, ROR2, ROS1, RPA1, BDNF, RPL5, RPN1, RPS6KB1 , (...)

View the complete list with 1627 more genes
Specificity
1 %
Genes
100 %

We have -4 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

OMIM ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH NEPHRONOPHTHISIS 9; NPHP9 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3 JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more